Skip to content
Hi-Doctor

How to Get CagriSema Online in Sevilla

Seeking CagriSema online in Sevilla? While this promising weight-loss peptide is not yet approved in the EU and Hi-Doctor does not offer it, legitimate, EU-approved alternatives are available.

24 April 2026
How to Get CagriSema Online in Sevilla

How to Get CagriSema Online in Sevilla

If you're looking to get CagriSema online in Sevilla, it's crucial to understand its current status. CagriSema is a novel weight-loss medication currently undergoing clinical trials and is not yet approved for prescription in the European Union. This means it cannot be legally prescribed or obtained through legitimate medical channels in Sevilla or any other EU country. Hi-Doctor does not offer CagriSema. Here's what CagriSema actually is, and what you CAN get today from an EU-licensed doctor.

What is CagriSema, and why isn't it a normal option yet?

CagriSema is an investigational drug combining two active compounds: semaglutide (a GLP-1 receptor agonist, similar to Ozempic and Wegovy) and cagrilintide (an amylin analogue). This combination aims to provide a more potent effect on weight loss, appetite regulation, and metabolic control. While early clinical trial results have been promising, CagriSema is still in Phase 3 trials. The European Medicines Agency (EMA) has not yet reviewed or approved it for commercial use. This means any sources claiming to offer CagriSema online are operating outside legal and medical regulations, posing significant safety and efficacy risks. Unregulated online sellers often provide counterfeit or substandard products that can be dangerous.

Proven weight-loss medications available online today

While CagriSema is not an option, several highly effective and EMA-approved weight-loss medications are available through an online consultation with an EU-licensed doctor:

  • Ozempic (semaglutide): Primarily for type 2 diabetes, often prescribed off-label for weight management when appropriate by an EU-licensed doctor.
  • Wegovy (semaglutide): A higher-dose formulation of semaglutide specifically approved for chronic weight management in eligible patients after medical review.
  • Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist, approved for type 2 diabetes and increasingly used for weight loss, offering significant efficacy when prescribed by a doctor.
  • Saxenda (liraglutide): A GLP-1 receptor agonist approved for chronic weight management, typically administered daily under medical supervision.

How to get a weight-loss prescription online in [your EU country]

Getting a prescription for an approved weight-loss medication through Hi-Doctor is a straightforward and secure process:

  1. Complete an online questionnaire: Spend 2–3 minutes providing your medical history and current health status in your private account.
  2. EU-licensed doctor reviews your case: An experienced EU-licensed doctor will individually assess your information to determine if a weight-loss treatment is medically appropriate for you.
  3. REMPE prescription in <24 hours: If approved, you'll receive a valid Spanish electronic prescription (REMPE), valid across the EU, delivered as a downloadable PDF to your account and email.
  4. Pick up at any EU pharmacy: Take your digital prescription to any pharmacy in Sevilla or any other EU country to collect your medication. The online consultation costs just 25 €, fully refundable if the doctor determines treatment is not suitable for your case.

Why choose Hi-Doctor over unregulated peptide sellers

Choosing a reputable, medically regulated platform like Hi-Doctor ensures your safety and the effectiveness of your treatment. We connect you with EU-licensed doctors who provide genuine medical oversight, prescribe real medications from real pharmacies, and offer auditable, RGPD-compliant communication. With over 50,000 patients served and a 4.8 Trustpilot rating, we stand for safety, transparency, and patient-centred care. This stands in stark contrast to the risks associated with 'research chemicals' or grey-market peptide vendors, which lack medical supervision, quality control, and legal compliance.

Frequently asked questions

Is CagriSema legal to buy online in Spain?

No, CagriSema is not legal to buy online in Spain or anywhere in the EU because it is not yet approved by the European Medicines Agency (EMA). Any sources offering it are operating illegally and may provide unsafe products.

When will CagriSema be available by prescription?

CagriSema is currently in Phase 3 clinical trials. Its availability depends on successful trial completion and subsequent regulatory approval by bodies like the EMA. This process typically takes several years from the current stage.

What's the closest approved alternative to CagriSema?

Approved medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) are the closest alternatives in terms of mechanism and efficacy for weight loss. They are both GLP-1 receptor agonists, with Mounjaro also including GIP agonism, similar to the multi-receptor approach of CagriSema.

How much does an online weight-loss consultation cost?

An online weight-loss consultation with an EU-licensed doctor through Hi-Doctor costs 25 €. This fee is automatically refunded if the doctor determines that treatment is not appropriate for your case.

Can I use a Hi-Doctor prescription at any pharmacy?

Yes, the REMPE electronic prescription issued by Hi-Doctor's EU-licensed doctors is valid at any pharmacy in any EU country, thanks to cross-border prescription directive 2011/24/EU. You can print it or show it on your phone.

Is Hi-Doctor trustworthy for online prescriptions?

Hi-Doctor uses EU-licensed doctors, provides genuine medications from real pharmacies, and has served over 50,000 patients with a 4.8 Trustpilot rating. All data is handled in a secure, RGPD-compliant environment, ensuring a safe and reliable service.

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.